510(k) Report

510(k) · Cleared

Recalled · Class II · 2018

Tina-Quant Albumin Gen 2

K101203510(k) TraditionalCleared Sep 10, 2010134-day reviewClass II21 CFR 866.5040Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Roche Diagnostics · DCF Albumin, Antigen, Antiserum, Control

Cleared on Sep 10, 2010 as substantially equivalent to K932950 (Boehringer Mannheim Corp., 1995) and 1 other predicate after a 134-day review. Its family tree reaches back 2 generations to 1989. 1 later device descends from it. It has been recalled once.

Decided
Sep 10, 2010
Review
134 days
Class
Class II
Product code
DCF
Recalls
1
Predicates
2

Its longest line of descent runs back 2 generations to K895883 (1989). 3 ancestors in all. 1 later device descends from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 1995: 1 other ancestor2012: 1 descendant clearedReference device: K953239 · Boehringer Mannheim/Hitachi 917 Analyzer · Boehringer Mannheim Corp. · 1995 · recalledK895883 · Beckman MA Microalbumin Reagent Kit · Beckman Instruments, Inc. · 1989K972929 · N Antiserum to Human Albumin · Behring Diagnostics, Inc. · 19971990200020102020
Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor 1 generation forward: 1 descendant K972929 · N Antiserum to Human Albumin · Behring Diagnostics, Inc. · 1997K895883 · Beckman MA Microalbumin Reagent Kit · Beckman Instruments, Inc. · 19890
  1. Root · 2 generations backK895883 Beckman MA Microalbumin Reagent KitBeckman Instruments, Inc. · 1989
  2. 1 generation backK972929 N Antiserum to Human AlbuminBehring Diagnostics, Inc. · 1997
  3. This deviceK101203 Tina-Quant Albumin Gen 2Roche Diagnostics · 2010
  4. Descendant · cites it directly · 0 of its ownK113072 Tina-Quant Albumin Gen.2Roche Diagnostics Operations · 2012

Most influential descendants

Showing 1 of 1 · See all
  • K113072Tina-Quant Albumin Gen.2Roche Diagnostics Operations · 2012 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K895883Beckman MA Microalbumin Reagent KitBeckman Instruments, Inc.1989—
−1K972929N Antiserum to Human AlbuminBehring Diagnostics, Inc.1997—
0 (this device)K101203Tina-Quant Albumin Gen 2Roche Diagnostics2010—
+1K113072Tina-Quant Albumin Gen.2Roche Diagnostics Operations2012—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199510

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201210
FIG. 1 — Lineage of K101203, 1989–2012Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DCF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K932950Tina-Quant Microalbumin
Summary page 2
…tantially equivalence equivalent to the Hitachi Microalbumnin urine assay. The Hitachi Microalbumin urine assay was cleared under K932950. The Serum/plasma and CSF applications of the Tina-quant Albumin Gen. 2 assa…
Boehringer Mannheim Corp.1995—
*K972929N Antiserum to Human Albumin
Summary page 2
…s of the Tina-quant Albumin Gen. 2 assays are substantially equivalent to the Behring Nephelometric method cleared in K972929. Substantial equivalence - comparison Feature Tina-quant Albumin Gen. 2 Assay…
Behring Diagnostics, Inc.1997—
†K953239Boehringer Mannheim/Hitachi 917 AnalyzerBoehringer Mannheim Corp.199518

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K113072Tina-Quant Albumin Gen.2Roche Diagnostics Operations20120

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Dec 14, 2018Class IIZ-1124-2019Device DesignCOBAS INTEGRA¿ 400 plus and cobas c 111 analyzers Additional Extra Wash Cycle Configurations and/or Batch Mode Needed for Specific Tests Due to Carry-over

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 21 years and passes through 3 companies; a new generation was cleared every 12.9 years on median.
  • None of the 3 ancestors has a recall.
  • Of its descendants, K113072 (Roche Diagnostics Operations, 2012) has gone furthest, with 0 descendants of its own.

How does its category compare?

All DCF devices

DCF Albumin, Antigen, Antiserum, Control: FDA decisions, review times, recalls and adverse event reports over 20 years. 2010, this device’s year, is highlighted.

FDA decisions per year · DCF

1in 2016

2009: 12010: 32011: 12012: 12013: 12014: 12015: 12016: 1
2007high 3 (2010) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DCF

167in 2010

2010: 167 days median
2007high 167 (2010)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DCF

1in 2019

2019: 1
2007high 1 (2019) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DCF

12in 2025

2008: 12017: 32018: 22019: 62020: 22021: 32022: 32023: 52024: 92025: 12
2007high 12 (2025) · low 0 (2007)2025

MAUDE reports naming product code DCF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—01
20091—00
2010316700
20111—00
20121—00
20131—00
20141—00
20151—00
20161—00
20170—03
20180—02
20190—16
20200—02
20210—03
20220—03
20230—05
20240—09
20250—012
20260—0—

What is it indicated for?

The Tina-quant Albumin Gen. 2 assay is an immunoturbidimetric assay intended for the quantitative determination of albumin in serum, plasma, urine, and CSF on Roche/Hitachi cobas c systems. Measurement of albumin aids in the diagnosis of kidney and intestinal diseases.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K101203: Tina-Quant Albumin Gen 2.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K101203

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026